Compounded semaglutide vs. Wegovy®
Same active ingredient, different products. One has been through FDA review and costs more; the other costs less and asks you to trust a pharmacy you have probably never heard of. Here is how to weigh it.
Short version: Wegovy® is an FDA-approved, manufactured semaglutide product with large clinical trials behind it. Compounded semaglutide is prepared by a pharmacy for an individual patient; it is legal when done properly, but it is not FDA-approved, not a generic, and the Wegovy® trial results have not been established for it. Compounded costs far less. If insurance covers Wegovy®, that usually settles it. If you are paying cash, compounded from a named, licensed pharmacy with a clinician monitoring you is a choice many people reasonably make. Reviewed October 2026.
What each one is
Wegovy® is semaglutide made by Novo Nordisk and approved by the FDA for chronic weight management, sold as a weekly injection in a prefilled pen. An oral Wegovy® tablet has also been approved more recently; check its current status and availability with your clinician. The FDA reviewed the product's trials, its manufacturing, and its labeling.
Compounded semaglutide is semaglutide prepared by a compounding pharmacy on a prescription for one patient, usually as an injectable vial or, from some programs, a tablet. Compounding is a long-standing, legal part of pharmacy. What it does not include is FDA review of the finished product for safety, effectiveness, or quality. It is also not a generic: a generic is an FDA-approved copy of a brand-name drug, and no generic Wegovy® exists.
Side by side
| Wegovy® | Compounded semaglutide | |
|---|---|---|
| FDA approval | Yes, for weight management | No; the pharmacy is regulated, the product is not reviewed |
| Made by | Novo Nordisk | A 503A compounding pharmacy or 503B outsourcing facility |
| Form | Prefilled pen; oral tablet more recently | Usually a vial you draw from; some tablets |
| Clinical trial evidence | Large trials of the product itself | Not established for compounded preparations |
| Typical cash cost | Hundreds of dollars a month or more | Roughly $69 to $250 a month at the programs we review |
| Insurance | Sometimes covered, often with prior authorization | Almost never covered |
| Consistency | Standardized | Varies by pharmacy |
The evidence question
Wegovy®'s approval rests on the STEP trials. In STEP 1, adults taking semaglutide 2.4 mg weekly alongside diet and activity changes lost about 15% of body weight on average over 68 weeks, with a wide range around that average. That result belongs to the manufactured product at that dose. It is reasonable to expect a correctly made compounded preparation with the same active ingredient to behave similarly, but nobody has run those trials, and "correctly made" is doing the work in that sentence. Any program that quotes Wegovy®'s trial numbers as what you will get from its compounded product is overstating what is known.
Where the risks of compounding actually are
Dosing errors. Pens deliver a set dose. Vials require drawing up a measured amount with a syringe, and the FDA has received reports of people drawing the wrong amount. If you get a vial, ask for a live walkthrough and repeat your dose in units back to the clinician.
Ingredient form. Some compounders have used semaglutide salt forms, such as semaglutide sodium, rather than the base form in the approved product, or have added ingredients like vitamins. The FDA has warned about salt forms specifically. Ask which form is used and whether anything is added.
Quality. The serious danger is not licensed pharmacies; it is unlicensed sellers marketing "research" semaglutide without a prescription. That is not compounding, and it is not on our list. A state-licensed pharmacy filling a valid prescription from a clinician who is following you is a different thing.
Legal status can change. Wide-scale compounding grew while brand-name semaglutide was in shortage. With the shortage resolved, routine copying of commercially available drugs is restricted, and in 2026 the FDA proposed removing semaglutide from the list of substances outsourcing facilities may compound in bulk. Programs continue to offer compounded semaglutide, often as personalized preparations, but the rules are moving. Ask any program what happens to your prescription if they change. Guide B covers this in more depth.
The cost difference
This is why compounded semaglutide exists in the market at all. At the programs we review, compounded semaglutide runs from about $69 a month (on a 12-month plan) to about $250 depending on the program, plan, and form. Cash prices for brand-name semaglutide are much higher, although manufacturers have introduced lower direct-to-consumer prices for self-pay patients that are worth checking. Over a year, the difference can run to thousands of dollars, and for many people that is the difference between treatment and none. Our price comparison shows the real numbers at a likely maintenance dose.
Switching between them
People do move between brand-name and compounded semaglutide, usually because of cost, insurance changes, or supply. It can be done, but it is a clinical decision, not a checkout one. Doses are not always directly interchangeable: a compounded vial is measured in units on a syringe, a pen is set in milligrams, and the concentration of a compounded preparation varies by pharmacy. A clinician should set the new dose, and you should confirm it in milligrams, not only in units.
If you are moving from brand-name to compounded, ask whether you will restart at a lower dose or continue where you were, and why. If you are moving from compounded to brand-name, expect your clinician to want to know exactly what you were taking, so keep your pharmacy labels. Either way, tell your regular doctor.
Questions that settle it for most people
- Does my insurance or Medicare cover Wegovy®? If yes, start there.
- If not, what is the full yearly cost of each option at my likely maintenance dose?
- For compounded: which pharmacy, which form of semaglutide, anything added, pen or vial?
- What happens to my prescription if compounding rules change?
How to decide
- Check your insurance first. If your plan or Medicare covers a brand-name GLP-1, your cost may be a copay, and the price argument for compounding disappears. Found runs a free insurance check and now accepts Medicare. Read our Found review.
- If you are paying cash and want brand-name, look at manufacturer self-pay options, and at Found, which prescribes brand-name medication with or without insurance.
- If compounded is the plan, choose a program that names its pharmacy type, prices the same at every dose, and has a clinician following you: SnagRx, HealthRX, or, for tablets, MEDGm. Our SnagRx, HealthRX, and MEDGm reviews explain the differences.
- Whatever you choose, ask the pharmacy's name and check its license on the state board site. That five-minute check is the most useful thing you can do.
The decision about which medication, if any, is right for you belongs to you and a licensed clinician who knows your history. The side effects and warnings in guide F apply to both.